Drug Details
PRM-151 is an anti-fibrotic immunomodulator being developed for treatment of fibrotic diseases.
Study Purpose
This Phase III Study will Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of PRM-151 Compared with Placebo in Participants with Idiopathic Pulmonary Fibrosis (IPF).
